rs515726180
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_015713.5(RRM2B):c.48G>A(p.Glu16Glu) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015713.5 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RRM2B | NM_015713.5 | c.48G>A | p.Glu16Glu | splice_region_variant, synonymous_variant | 1/9 | ENST00000251810.8 | NP_056528.2 | |
RRM2B | NM_001172478.2 | c.48G>A | p.Glu16Glu | splice_region_variant, synonymous_variant | 1/8 | NP_001165949.1 | ||
RRM2B | NM_001172477.1 | c.-5G>A | 5_prime_UTR_variant | 1/9 | NP_001165948.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RRM2B | ENST00000251810.8 | c.48G>A | p.Glu16Glu | splice_region_variant, synonymous_variant | 1/9 | 1 | NM_015713.5 | ENSP00000251810.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248684Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134776
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461432Hom.: 0 Cov.: 33 AF XY: 0.0000275 AC XY: 20AN XY: 727052
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 15, 2023 | Previously reported as heterozygous in the adult individuals of two unrelated families with progressive external ophthalmoplegia, ptosis, and muscle fatigue or weakness with ragged-red fibers and multiple mtDNA deletions identified on muscle biopsy (PMID: 23107649); Functional analysis demonstrated this variant results in abnormal splicing (PMID: 23107649); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24741716, 28812649, 32313153, 23107649) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2023 | This sequence change affects codon 16 of the RRM2B mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the RRM2B protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has been observed in individual(s) with autosomal recessive mitochondrial myopathy (PMID: 32313153). This variant has been reported in individual(s) with autosomal dominant progressive external ophthalmoplegia (PMID: 23107649); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 132103). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in premature truncating codon 26 codons beyond exon 1 and introduces a premature termination codon (PMID: 23107649). The resulting mRNA is expected to undergo nonsense-mediated decay. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 01, 2022 | - - |
Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction;C2749861:Mitochondrial DNA depletion syndrome 8a;C2751319:Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 29, 2024 | - - |
Mitochondrial disease Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Wellcome Centre for Mitochondrial Research, Newcastle University | Apr 07, 2017 | - - |
Mitochondrial DNA depletion syndrome 8a Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Kids Research, The Children's Hospital at Westmead | - | - - |
RRM2B-related mitochondrial disease Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at